AARD Aardvark Therapeutics, Inc.

NASDAQ

$4.99

Aardvark Therapeutics, Inc. (AARD) Earnings News

Earnings press releases, previews and reviews for Aardvark Therapeutics, Inc. (AARD), newest first.

Tuesday August 11, 2026 4:53 PM ET

Aardvark Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Updates

Thursday May 7, 2026 8:00 AM ET

Aardvark Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Updates